MorphoSys's vision

MorphoSys is committed to develop exceptional new treatments for patients suffering from serious diseases. A leader in the field of therapeutic antibodies today, MorphoSys is driven by the ambition of creating the most valuable pipeline of biopharmaceuticals in the biotechnology industry.

Events

15. Wed
January

38th Annual J.P. Morgan Healthcare Conference

San Francisco, CA, USA
29. Fri
May

ASCO Annual Meeting

Chicago, Illinois, USA